2021 RESEARCH
- Archives -William Flavahan receives Distinguished Scientist Award for groundbreaking brain cancer research
William Flavahan, PhD, has received a four-year, $600,000 award from the Sontag Foundation to advance his studies of the genetic processes leading to brain tumors.
Caterina Strambio De Castillia and her team advance efforts to set microscopy data standards
UMass Chan Medical School researcher and Chan Zuckerberg Initiative Imaging Scientist Caterina Strambio De Castillia, PhD, is the senior author on two papers and a co-author on four more published in the December issue of Nature Methods.
Han lab developing light-activated immune cell therapy for cancers
Gang Han, PhD, said newly developed nano-optogenetic immunotherapy represents a new generation of personalized cancer treatment, in which precise control of the timing, location and dosage of T-cell activation could be tailored to an individual patient.
UMass Chan researchers explore parents’ attitudes toward pediatric COVID-19 vaccines
Parents who are vaccinated against COVID-19 are most likely to vaccinate their children, according to an analysis by researchers at UMass Chan Medical School.
Flotte lab to develop gene therapy models for genetic lung disease
Researchers from UMass Chan Medical School have received a five-year $13.6 million program project grant from the National Heart, Lung and Blood Institute to develop new gene therapy models for alpha-1 antitrypsin deficiency, a chronic, debilitating genetic lung disease that shortens the lifespan.
UMass Cancer Center funds five UMass Chan research projects
The UMass Cancer Center Pilot Project Program has awarded seed grants to five UMass Chan Medical School research projects to enable investigators to gather pilot data for external cancer-focused funding.
LISTEN: What does it take to persuade people to get vaccinated against COVID-19?
In a new Voices of UMass Chan podcast, two UMass Chan Medical School researchers who have been tracking vaccine acceptance since the COVID-19 pandemic, share reliable advice based on their findings.
Research from McCormick lab identifies new link between microbiome and intestinal function
Scientists from the McCormick lab at UMass Chan Medical School and the University of Bath have identified a new connection between molecules produced by the microbiome and the function of a human protein that impacts gut inflammation.
Liisa Selin and Anna Gil study links between viral infections and ME/CFS
UMass Chan Medical School researchers are seeking insights into links between myalgic encephalomyelitis/chronic fatigue syndrome and viral infections, including COVD-19, with a five-year, $2.5 million grant from the National Institute of Allergy and Infectious Diseases.
Sio Gene Therapies reports positive interim data for gene therapy trial
Sio Gene Therapies, a clinical-stage company focused on developing gene therapies for neurodegenerative diseases, presented positive interim data from its Phase I/II study of AXO-AAV-GM1, an adeno-associated viral vector-based gene therapy candidate for GM1 gangliosidosis that was licensed from UMass Chan.